IOM Calls On Physicians To Reject Financial Arrangements With Drugmakers

Main Category: Primary Care / General Practice
Also Included In: Pharma Industry / Biotech Industry;  Medical Devices / Diagnostics
Article Date: 30 Apr 2009 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:5 stars

5 (1 votes)


The Institute of Medicine on Tuesday issued a set of guidelines that call on physicians, medical professionals in academia and health service providers to make public all payments and gifts they receive from the drug and medical device industries, the New York Times reports (Harris, New York Times, 4/29).

The report -- by the IOM Committee on Conflict of Interest in Medical Research, Education and Practice -- recommends that physicians, medical schools and hospitals not accept any gifts of any value from drugmakers or device makers; refrain from meeting with company sales representatives without an appointment or express invitation; and refuse product samples unless they can be used for low-income patients (Norman, CQ HealthBeat, 4/28). The report also recommends that Congress pass legislation that would require medical device and pharmaceutical companies to disclose publicly all payments they make to physicians (New York Times, 4/29).

In addition, the report proposes the elimination of industry influence in continuing medical education courses, which are required for many U.S. physicians (CQ HealthBeat, 4/28). Drugmakers and medical device makers currently subsidize the cost of such courses, often allowing physicians to take them at no cost, the Times reports (New York Times, 4/29). According to IOM, the medical industry's share of the costs for the courses has increased over the past decade from 34% to 48% (Perrone, AP/Houston Chronicle, 4/28). The report calls for a system to ensure the courses are not influenced by the industry.

Committee Chair Bernard Lo, a professor of medicine and director of the Program in Medical Ethics at the University of California-San Francisco, said, "It is time to end a number of long-accepted practices that create unacceptable conflicts of interest, threaten the integrity of the medical profession and erode public trust while providing no meaningful benefits to patients or society" (CQ HealthBeat, 4/28).

The report is available online.

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our primary care / general practice section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "IOM Calls On Physicians To Reject Financial Arrangements With Drugmakers." Medical News Today. MediLexicon, Intl., 30 Apr. 2009. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/148253.php>

APA
Kaiser. (2009, April 30). "IOM Calls On Physicians To Reject Financial Arrangements With Drugmakers." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/148253.php.

Please note: If no author information is provided, the source is cited instead.


Primary Care / General Practice

Most Popular Articles



Follow Our Primary Care News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Primary Care / General Practice Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »